Abstract

The evolutionary trajectories of early lung adenocarcinoma (LUAD) have not been fully elucidated. We hypothesize that genomic analysis between pre-invasive and invasive components will facilitate the description of LUAD evolutionary patterns. We micro-dissect malignant pulmonary nodules (MPNs) into paired pre-invasive and invasive components for panel-genomic sequencing and recognize three evolutionary trajectories. Evolutionary mode 1 (EM1) demonstrates none of the common driver events between paired components, but another two modes, EM2A and EM2B, exhibit critical private alterations restricted to pre-invasive and invasive components, respectively. When ancestral clones harbor EGFR mutations, truncal mutation abundance significantly decrease after the acquisition of invasiveness, which may be associated with the intratumoral accumulation of infiltrated B cells. Harboring EGFR mutations is critical to the selective pressure and further impacts the prognosis. Our findings extend the understanding of evolutionary trajectories during invasiveness acquisition in early LUAD.

Invasive early stage lung adenocarcinoma has a heterogeneous prognosis. Here, the authors microdissect malignant pulmonary nodules to invasive and preinvasive components and study the mutations that are common or private between the lesions, allowing them to understand the evolutionary path of the tumours.

Details

Title
Tumor evolutionary trajectories during the acquisition of invasiveness in early stage lung adenocarcinoma
Author
Wang, Siwei 1 ; Du Mulong 2 ; Zhang, Jingyuan 3 ; Xu Weizhang 1 ; Yuan Qianyu 4 ; Li, Ming 1 ; Wang, Jie 5 ; Zhu, Hongyu 1 ; Wang, Yuzhuo 6 ; Wang, Cheng 7 ; Gong Yuhua 8   VIAFID ORCID Logo  ; Wang, Xiaonan 9 ; Hu, Zhibin 7 ; Christiani, David C 4   VIAFID ORCID Logo  ; Xu, Lin 10 ; Shen Hongbing 7 ; Yin Rong 11   VIAFID ORCID Logo 

 Nanjing Medical University Affiliated Cancer Hospital & Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research, Department of Thoracic Surgery, Jiangsu Key Laboratory of Molecular and Translational Cancer Research, Nanjing, P.R. China (GRID:grid.452509.f) (ISNI:0000 0004 1764 4566) 
 Nanjing Medical University, Department of Biostatistics, Center for Global Health, School of Public Health, Nanjing, P.R. China (GRID:grid.89957.3a) (ISNI:0000 0000 9255 8984); Harvard T. H. Chan School of Public Health, Department of Environmental Health, Boston, USA (GRID:grid.38142.3c) (ISNI:000000041936754X); Harvard T. H. Chan School of Public Health, Department of Epidemiology, Boston, USA (GRID:grid.38142.3c) (ISNI:000000041936754X); Massachusetts General Hospital/Harvard Medical School, Department of Medicine, Boston, USA (GRID:grid.38142.3c) 
 Nanjing Medical University Affiliated Cancer Hospital & Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research, Department of Pathology, Nanjing, P.R. China (GRID:grid.452509.f) (ISNI:0000 0004 1764 4566) 
 Harvard T. H. Chan School of Public Health, Department of Environmental Health, Boston, USA (GRID:grid.38142.3c) (ISNI:000000041936754X); Harvard T. H. Chan School of Public Health, Department of Epidemiology, Boston, USA (GRID:grid.38142.3c) (ISNI:000000041936754X); Massachusetts General Hospital/Harvard Medical School, Department of Medicine, Boston, USA (GRID:grid.38142.3c) 
 Nanjing Medical University Affiliated Cancer Hospital & Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research, Department of Science and Technology, Nanjing, P.R. China (GRID:grid.452509.f) (ISNI:0000 0004 1764 4566); Jiangsu Biobank of Clinical Resources, Biobank of Lung Cancer, Nanjing, P.R. China (GRID:grid.452509.f) 
 Nanjing Medical University Affiliated Cancer Hospital & Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research, Department of Thoracic Surgery, Jiangsu Key Laboratory of Molecular and Translational Cancer Research, Nanjing, P.R. China (GRID:grid.452509.f) (ISNI:0000 0004 1764 4566); Nanjing Medical University, Department of Epidemiology and Biostatistics, International Joint Research Center on Environment and Human Health, Center for Global Health, School of Public Health, Nanjing, P.R. China (GRID:grid.89957.3a) (ISNI:0000 0000 9255 8984) 
 Nanjing Medical University, Department of Epidemiology and Biostatistics, International Joint Research Center on Environment and Human Health, Center for Global Health, School of Public Health, Nanjing, P.R. China (GRID:grid.89957.3a) (ISNI:0000 0000 9255 8984) 
 Geneplus-Beijing Institute, Beijing, P.R. China (GRID:grid.89957.3a) 
 Geneseeq-Nanjing Technology Inc., Nanjing, P.R. China (GRID:grid.89957.3a) 
10  Nanjing Medical University Affiliated Cancer Hospital & Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research, Department of Thoracic Surgery, Jiangsu Key Laboratory of Molecular and Translational Cancer Research, Nanjing, P.R. China (GRID:grid.452509.f) (ISNI:0000 0004 1764 4566); Nanjing Medical University, Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing, P.R. China (GRID:grid.89957.3a) (ISNI:0000 0000 9255 8984) 
11  Nanjing Medical University Affiliated Cancer Hospital & Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research, Department of Thoracic Surgery, Jiangsu Key Laboratory of Molecular and Translational Cancer Research, Nanjing, P.R. China (GRID:grid.452509.f) (ISNI:0000 0004 1764 4566); Nanjing Medical University Affiliated Cancer Hospital & Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research, Department of Science and Technology, Nanjing, P.R. China (GRID:grid.452509.f) (ISNI:0000 0004 1764 4566); Jiangsu Biobank of Clinical Resources, Biobank of Lung Cancer, Nanjing, P.R. China (GRID:grid.452509.f); Nanjing Medical University, Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing, P.R. China (GRID:grid.89957.3a) (ISNI:0000 0000 9255 8984) 
Publication year
2020
Publication date
2020
Publisher
Nature Publishing Group
e-ISSN
20411723
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2473268109
Copyright
© The Author(s) 2020. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.